Among the secondary end points , the demand for PCI/CABG was 3.01 % in the treatment group and 4.51 % in the control group , with a reduction of relative risk by 33.3 % in treatment group ( P = 0.097 ) ; ( 4 ) The total mortality was lower in treatment group than control group , with a reduction of relative risk by 33.0 % in treatment group ( 5.19 % vs 7.74 % P = 0.0003 ) .
